These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 19096223

  • 1. Erythropoietin prevents diabetes-induced podocyte damage.
    Schiffer M, Park JK, Tossidou I, Bartels J, Shushakova N, Menne J, Fliser D.
    Kidney Blood Press Res; 2008; 31(6):411-5. PubMed ID: 19096223
    [Abstract] [Full Text] [Related]

  • 2. Erythropoietin ameliorates podocyte injury in advanced diabetic nephropathy in the db/db mouse.
    Loeffler I, Rüster C, Franke S, Liebisch M, Wolf G.
    Am J Physiol Renal Physiol; 2013 Sep 15; 305(6):F911-8. PubMed ID: 23825071
    [Abstract] [Full Text] [Related]

  • 3. Darbepoetin alfa protects podocytes from apoptosis in vitro and in vivo.
    Logar CM, Brinkkoetter PT, Krofft RD, Pippin JW, Shankland SJ.
    Kidney Int; 2007 Aug 15; 72(4):489-98. PubMed ID: 17554257
    [Abstract] [Full Text] [Related]

  • 4. The continuous erythropoietin receptor activator affects different pathways of diabetic renal injury.
    Menne J, Park JK, Shushakova N, Mengel M, Meier M, Fliser D.
    J Am Soc Nephrol; 2007 Jul 15; 18(7):2046-53. PubMed ID: 17554150
    [Abstract] [Full Text] [Related]

  • 5. Chronic erythropoietin treatment affects different molecular pathways of diabetic cardiomyopathy in mouse.
    Shushakova N, Park JK, Menne J, Fliser D.
    Eur J Clin Invest; 2009 Sep 15; 39(9):755-60. PubMed ID: 19614950
    [Abstract] [Full Text] [Related]

  • 6. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
    Susztak K, Raff AC, Schiffer M, Böttinger EP.
    Diabetes; 2006 Jan 15; 55(1):225-33. PubMed ID: 16380497
    [Abstract] [Full Text] [Related]

  • 7. Renoprotection by continuous erythropoietin receptor activator in puromycin aminonucleoside-induced nephrotic syndrome.
    Aizawa K, Takeda S, Tashiro Y, Yorozu K, Hirata M, Kanada H, Moriguchi Y, Endo K.
    Am J Nephrol; 2012 Jan 15; 36(5):419-26. PubMed ID: 23128049
    [Abstract] [Full Text] [Related]

  • 8. Erythropoietin protects podocytes from damage by advanced glycation end-products.
    Ruester C, Franke S, Bondeva T, Wolf G.
    Nephron Exp Nephrol; 2011 Jan 15; 117(1):e21-30. PubMed ID: 20689331
    [Abstract] [Full Text] [Related]

  • 9. Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure.
    Bahlmann FH, Song R, Boehm SM, Mengel M, von Wasielewski R, Lindschau C, Kirsch T, de Groot K, Laudeley R, Niemczyk E, Güler F, Menne J, Haller H, Fliser D.
    Circulation; 2004 Aug 24; 110(8):1006-12. PubMed ID: 15302785
    [Abstract] [Full Text] [Related]

  • 10. Dysregulation of low-density lipoprotein receptor contributes to podocyte injuries in diabetic nephropathy.
    Zhang Y, Ma KL, Liu J, Wu Y, Hu ZB, Liu L, Liu BC.
    Am J Physiol Endocrinol Metab; 2015 Jun 15; 308(12):E1140-8. PubMed ID: 25921580
    [Abstract] [Full Text] [Related]

  • 11. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
    Zhang M, Liu M, Xiong M, Gong J, Tan X.
    J Ethnopharmacol; 2012 May 07; 141(1):111-8. PubMed ID: 22353431
    [Abstract] [Full Text] [Related]

  • 12. 1,25-Dihydroxyvitamin D(3) prevents puromycin aminonucleoside-induced apoptosis of glomerular podocytes by activating the phosphatidylinositol 3-kinase/Akt-signaling pathway.
    Xiao H, Shi W, Liu S, Wang W, Zhang B, Zhang Y, Xu L, Liang X, Liang Y.
    Am J Nephrol; 2009 May 07; 30(1):34-43. PubMed ID: 19202327
    [Abstract] [Full Text] [Related]

  • 13. Failure to phosphorylate AKT in podocytes from mice with early diabetic nephropathy promotes cell death.
    Tejada T, Catanuto P, Ijaz A, Santos JV, Xia X, Sanchez P, Sanabria N, Lenz O, Elliot SJ, Fornoni A.
    Kidney Int; 2008 Jun 07; 73(12):1385-93. PubMed ID: 18385666
    [Abstract] [Full Text] [Related]

  • 14. BMP7 is a podocyte survival factor and rescues podocytes from diabetic injury.
    Mitu GM, Wang S, Hirschberg R.
    Am J Physiol Renal Physiol; 2007 Nov 07; 293(5):F1641-8. PubMed ID: 17804487
    [Abstract] [Full Text] [Related]

  • 15. The effect of low-dose Continuous Erythropoietin receptor activator in an experimental model of acute Cyclosporine A induced renal injury.
    Meerwein C, Korom S, Arni S, Inci I, Weder W, Jungraithmayr W.
    Eur J Pharmacol; 2011 Dec 05; 671(1-3):113-9. PubMed ID: 21968143
    [Abstract] [Full Text] [Related]

  • 16. Erythropoietin Reduces Insulin Resistance via Regulation of Its Receptor-Mediated Signaling Pathways in db/db Mice Skeletal Muscle.
    Pan Y, Yang XH, Guo LL, Gu YH, Qiao QY, Jin HM.
    Int J Biol Sci; 2017 Dec 05; 13(10):1329-1340. PubMed ID: 29104499
    [Abstract] [Full Text] [Related]

  • 17. Huangkui capsule alleviates doxorubicin-induced proteinuria via protecting against podocyte damage and inhibiting JAK/STAT signaling.
    Zhao L, Han S, Chai C.
    J Ethnopharmacol; 2023 Apr 24; 306():116150. PubMed ID: 36608778
    [Abstract] [Full Text] [Related]

  • 18. Mechanical stretch and prostaglandin E2 modulate critical signaling pathways in mouse podocytes.
    Faour WH, Thibodeau JF, Kennedy CR.
    Cell Signal; 2010 Aug 24; 22(8):1222-30. PubMed ID: 20362052
    [Abstract] [Full Text] [Related]

  • 19. Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production.
    Toyonaga J, Tsuruya K, Ikeda H, Noguchi H, Yotsueda H, Fujisaki K, Hirakawa M, Taniguchi M, Masutani K, Iida M.
    Nephrol Dial Transplant; 2011 Aug 24; 26(8):2475-84. PubMed ID: 21220752
    [Abstract] [Full Text] [Related]

  • 20. β Common receptor integrates the erythropoietin signaling in activation of endothelial nitric oxide synthase.
    Su KH, Shyue SK, Kou YR, Ching LC, Chiang AN, Yu YB, Chen CY, Pan CC, Lee TS.
    J Cell Physiol; 2011 Dec 24; 226(12):3330-9. PubMed ID: 21321940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.